Regulatory approval

Published by the Health Products Regulatory Authority. Approved

Adjuvant treatment of hormone receptor-positive early invasive breast cancer in postmenopausal women.

This is written in the approval document.

Citation

Laboratoires Juvise Pharmaceuticals. Arimidex 1mg Film-coated Tablets (Anastrozole) [summary of product characteristics]. Health Products Regulatory Authority website. https://assets.hpra.ie/products/Human/23881/Licence_PA23154-001-001_09062021161903.pdf. Revised June 2021. Accessed May 25, 2025.

View API

Therapeutic response

Precision oncology relationships for therapeutic response derived from this regulatory approval.

Organizations Biomarkers Cancer types Therapies
HPRA (1) ER positive Invasive Breast Carcinoma Anastrozole
HPRA (1) PR positive Invasive Breast Carcinoma Anastrozole
HPRA (1) ER positive, PR positive Invasive Breast Carcinoma Anastrozole